BenfoTeam scientists have found that thiamine (vitamin B1) does not enter the brains of people with early Alzheimer’s disease despite having a sufficient supply of thiamine in their blood.
Fortunately, there is also evidence that this problem with thiamine in the brain may be overcome by increasing the amount of thiamine in the blood far above usual levels. The BenfoTeam trial is testing a lab-made version of thiamine, benfotiamine. BenfoTeam tests if increasing thiamine in the blood slows cognitive decline in people with early Alzheimer’s disease, including mild cognitive impairment and mild dementia.
Enroll Here